Organization | Smith Kline and French

Smith Kline and French Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2015

NCT02246166

First Marketed Drug

1976

amphetamine (Adderall)

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Alternative names

Sino-American Tianjin Smith Kline & French Laboratories Ltd | SMITH KLINE & FRENCH

Active Ingredients

Marketed Drugs (1)

amphetamine (Adderall) (1976)

Drugs in Phase 4 Trials (4)

acetaminophen (tylenol) (1 trial)

dexchlorpheniramine maleate (polaramine) (1 trial)

dextromethorphan (delsym) (1 trial)

pseudoephedrine (Benylin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Common Cold (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 1
# of Trial APIs: 4